CompletedPhase 2NCT00758225

Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)

Studying Duchenne muscular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Santhera Pharmaceuticals
Principal Investigator
Prof Gunnar Buyse, MD PhD
Universitaire Ziekenhuizen KU Leuven
Intervention
Idebenone(drug)
Enrollment
21 enrolled
Eligibility
MALE
Timeline
20082011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00758225 on ClinicalTrials.gov

Other trials for Duchenne muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Duchenne muscular dystrophy

← Back to all trials